icon
Leave a message
google.com, pub-4988895920620082, DIRECT, f08c47fec0942fa0

Sunday, December 14, 2014

Ebola Vaccine Trial Halted Temporarily After Joint Pains: Geneva Hospital

A clinical trial of an Ebola vaccine developed by Merck and NewLink has been halted temporarily as a precautionary measure after four patients complained of joint pains, the University of Geneva Hospital said on Thursday.




"They are all fine and being monitored regularly by the medical team leading the study," it said in a statement.



The trials will resume on Jan. 5, on up to 15 volunteers, after checks to ensure that the joint pain symptoms in hands and feet were "benign and temporary", the hospital said.

Fifty nine volunteers have been vaccinated so far in the
human safety trials in Geneva, which began on Nov. 10.

Scientists are racing to develop Ebola vaccines after the world's worst outbreak of the virus has killed more than 6,000 people in West Africa so far this year.



Separately, safety data from a trial of a GlaxoSmithKline Ebola vaccine on 120 volunteers is "satisfactory", the University of Lausanne Hospital said on Thursday.

The first results of the Lausanne hospital's trial of the GSK vaccine and whether it provides immunity against the virus are expected by the end of December, the university said in a statement.

"The safety data looked satisfactory so far," said Professor Blaise Genton, who is leading the GSK trial in Lausanne. "General symptoms such as fever might be slightly more frequent, though no serious adverse event has been observed so far."

Scientists reported on Nov. 26 in the New England Journal of Medicine that another version of the experimental GSK vaccine caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage trial. CONTINUE READING

MEDICALDAILY

Related Posts:

  • Lara Logan of CBS News Quarantined Lara Logan of CBS News is being quarantined in a South Africa hotel for three weeks as a precaution after visiting an American-run hospital treating Ebola patients in Liberia for a "60 Minutes" report that aired Sunday. … Read More
  • Ebola Appears To Be Slowing In Liberia: WHO The rate of new Ebola infections in Liberia appears to be declining and could represent a genuine trend, the World Health Organization said Wednesday, but the epidemic is far from over. The disease is still raging in … Read More
  • Three Reasons Why Most U.S. Patients Have Survived Ebola Virus Grim tales of the thousands of sick, dead, and dying from the Ebola outbreak in West Africa contrast greatly with the high success rate of medical treatment for a small number of Ebola patients in the United States. W… Read More
  • How Bad Is Ebola in the U.S?. Top medical experts studying the spread of Ebola say the public should expect more cases to emerge in the United States by year's end as infected people arrive here from West Africa, including American doctors and nurses … Read More
  • Legacy of SARS in Asia offers lessons for Ebola fight The flu-like Severe Acute Respiratory Syndrome infected 1,800 people and took 299 lives in the southern Chinese city.  Panic spread, emptying usually busy streets and restaurants and causing the property ma… Read More

0 comments:

Post a Comment

Contact Form

Name

Email *

Message *